TORONTO - Sabrina Apitz-Grossman was told 13 months ago that she had about 12 to 18 months to live.
asserted
she → tell → months
A rare form of cancer in the 31-year-old’s knee had metastasized, spreading to her lungs.
asserted
form → metastasize → lungs
She has undergone radiotherapy, chemotherapy and surgeries, though the synovial sarcoma couldn’t be fully removed.
asserted
sarcoma → undergo → radiotherapy
Apitz-Grossman’s doctors are recommending a treatment approved in the United States but unavailable in Ontario.
asserted
doctors → recommend → Ontario
She needs it urgently but the Ontario Health Insurance Plan turned her down for out-of-country coverage.
asserted
Plan → need → coverage
An appeal failed, as did an application under a Case-by-Case Review Program to get special permission for the treatment to be administered at the Princess Margaret Cancer Centre in Toronto.
asserted
treatment → fail → Toronto
She is still fighting.
asserted
She → fight → ?
“I so desperately would love to turn 32,” she said.
asserted
she → love → 32
Apitz-Grossman and other Ontarians with Stage 4 cancer told by their doctors that they are good candidates for treatments unavailable in the province were buoyed last month when 37-year-old Alex Shved, in a similar situation, won a court challenge against his OHIP out-of-country denial.
asserted
Shved → tell → denial
But their hopes were dashed when Health Minister Sylvia Jones responded to the court ruling by changing the rules.
asserted
Jones → dash → rules
Drug treatments will now only be funded out of country if they are already funded within the province but access is temporarily unavailable or delayed, a set of circumstances some patients see as impossibly narrow.
asserted
patients → fund → circumstances
The government said it clarified in regulation what was already long-standing policy.
asserted
what → say → regulation
“We’re protecting Ontario patients and taxpayers from price gouging and protecting their access to life-saving medications that would otherwise only be available in the United States or overseas,” Jones wrote in a statement.
asserted
Jones → protect → statement
“This change supports a consistent, fair and transparent approach to funding decisions, protects the integrity of Ontario’s world-class drug approval process and will help avoid up to $5.2 billion in additional costs to Ontario’s health-care system every year.”
Framing the move as a cost-saving measure is not sitting right with Apitz-Grossman.
asserted
Framing → support → Grossman
“Are we saying that we could save like 5,000 or more people’s lives, and they’re proud of themselves for not doing that?” she said.
uncertain
she → say → that
“Is this supposed to be good news that we’re not going to save those people, so that we can instead buy a couple more private jets?”
asserted
we → suppose → jets
Ontario Premier Doug Ford came under fire earlier this year for a government purchase of a $29-million private jet and quickly returned it.
The treatment Apitz-Grossman is seeking, Tecelra, is a personalized therapy made from a patient’s own T-cells, a type of white blood cell.
asserted
Grossman → come → cell
Nearly half of patients in Apitz-Grossman’s situation respond to the treatment, and among those who respond, there is a 90 per cent chance of survival after a year and 70 per cent after two years, according to her oncologist.
uncertain
who → respond → oncologist
But the treatment is costly, at US$727,000, Apitz-Grossman said.
asserted
Grossman → say → 727,000
She feels terrible guilt for seeking such a pricey treatment, she said, but she wants to live.
asserted
she → feel → treatment
“There has never been a moment where I have thought to myself, ‘Gosh, I wish that patient who was in the ICU for weeks and who it cost hundreds of thousands of dollars to save, hadn’t been saved,’” Apitz-Grossman said.
asserted
Grossman → think → dollars
The origin of Jones’ $5.2-billion figure was unclear in her press release, and a government official later explained that it would be the additional cost if the province entirely stopped negotiating prices with drug manufacturers for public coverage in Ontario.
uncertain
province → explain → Ontario
OHIP’s reason for denying Apitz-Grossman, Shved and others out-of-country drug treatment funding is that routinely paying for such requests while drugs are undergoing review for funding in Ontario would “undermine the incentive structure that encourages manufacturers to participate in Canada’s drug review processes.”
asserted
that → deny → processes
Kevin Nash, 59, has metastatic melanoma and is seeking the same tumour-infiltrating lymphocyte therapy as Shved.
asserted
Nash → have → Shved
Nash’s out-of-country application and subsequent appeal were also denied, and he does not believe the government’s reasoning.
asserted
he → deny → reasoning
“These companies make billions of dollars a year, not a billion, billions of dollars a year,” he said.
asserted
he → make → dollars
“Do you think that they care one bit whether Kevin Nash goes to Buffalo for a treatment?
asserted
Nash → think → treatment
That’s so preposterous.”
asserted
That → ’ → ?
In Apitz-Grossman’s case, the manufacturer of Tecelra has said it has no plans to apply for approval in Canada.
asserted
it → say → Canada
That means there is no review process in this case to undermine, she noted.
asserted
she → mean → case
Holly Wardlow, 61, is in a similar boat, with the government denying coverage through its Case-by-Case Review Program for a medication to treat her rare form of liver cancer because the drug was “expected to be reviewed for public funding in Ontario.”
asserted
drug → deny → Ontario
That’s despite the manufacturer submitting two letters telling the province it has no plans to apply for approval in Canada.
asserted
it → ’ → Canada
“We just thought, ‘Well, this doesn’t make any sense,’” Wardlow said.
asserted
Wardlow → think → sense
“We provided evidence that there is not going to be a population-based review.
asserted
We → provide → evidence
This drug is never going to be approved in Canada, let alone Ontario, because the manufacturer is not going to make an application, and they have evidence of that.
asserted
they → go → that
And yet they provided the same reason for denying funding.
asserted
they → provide → funding
Wardlow and her husband have been paying $78,000 a month for her to receive infusions in Ontario every two weeks, and her tumour has been shrinking with almost no side-effects, she said.
asserted
she → pay → effects
Their savings have been depleted and they have now started a GoFundMe.
asserted
they → deplete → GoFundMe
“I’m getting out there and trying to stay fit, partly because I can, and partly because the weather is beautiful, and partly because I’m thinking ahead that surgery may be possible in the future,” Wardlow said.
uncertain
Wardlow → get → future
This report by The Canadian Press was first published Oct. 21, 2026.
asserted
report → publish → Press
The Aporia
